Navigation Links
AEterna Zentaris Closes Sale of Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners
Date:12/3/2008

All amounts are in U.S. dollars

QUEBEC CITY, Dec. 3 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, announces that it has completed the transaction under the previously announced purchase and sale agreement with Cowen Healthcare Royalty Partners, L.P. ("CHRP") relating to AEterna Zentaris' rights to royalties on future sales of Cetrotide(R) covered by its license agreement with Merck Serono. AEterna Zentaris received $52.5 million from CHRP at closing, less certain transaction costs. Under the terms of the agreement with CHRP, AEterna Zentaris would receive an additional payment of $2.5 million from CHRP contingent on 2010 net sales of Cetrotide(R) reaching a specified level.

About Cetrotide(R) (cetrorelix)

Cetrotide(R) (cetrorelix) was the first luteinizing hormone-releasing hormone (LHRH) antagonist treatment approved for in vitro fertilization. It is administered to women to prevent premature ovulation in order to increase fertility success rate. Developed in cooperation with Medicine Nobel-Prize winner, Professor Andrew Schally of Veterans Affairs, Miami, Florida, it was launched in Europe in 1999 and in the United States in 2001. Cetrotide(R) is currently marketed worldwide by Merck Serono, except for Japan where it is marketed by Nippon Kayaku and Shionogi.

Cetrorelix is also currently in a Phase 3 program in benign prostatic hyperplasia involving 1,500 patients in North America and Europe. First results are expected in Q3 2009 with an NDA filing to follow in 2010 and potential launch in 2011.

About Cowen Healthcare Royalty Partners

Cowen Healthcare Royalty Partners ("CHRP") is a global healthcare private equity firm with over $500 million in capita
'/>"/>

SOURCE AETERNA ZENTARIS INC.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
3. AEterna Zentaris Announces Outcome of Managements Strategic Review
4. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
5. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
6. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
7. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
8. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
9. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
10. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
11. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...Gabon, December 2 , - "Bo...m and Heritage" , Coinciding with the Int...,Gabonese Republic is hosting an international con...guarding biological resources in Africa. The,confe...ders, ministers,scientific experts, private compa...
(Date:12/2/2009)...., Dec. 2 /PRNewswire-Asia-FirstCall/ -- Emerald D... Bulletin Board: EMDY), a leading,producer and dis...wder and,soybean products in China, today announce...issue of US Food & Drink Executive, a quarterl...tives in the food and beverage industry. , ...
(Date:12/2/2009)...ec. 2 According to the National In...ricans diagnosed with diabetes already have some s...y, damage to the retina caused by leaky blood vess...diabetes and is one of the most feared diabetic co...ients who,ve had diabetes for 10 years or more wil...
(Date:12/1/2009)...ec. 1 Reportlinker.com announces t...ts catalogue: ,, Emerging Clinical Trial Locat...nging healthcare and regulatory environment ,,...inical-Trial-Locations---Eastern-Europe-Market-dyn...nvironment.html ,, Over the last decade pharma...
Breaking Biology Technology:Libreville International Conference 2-3 June 2010 2Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8
...ra-Fine Beam Shaping Device Optimized for Targetin...Stereotactic Radiotherapy and Radiosurgery, PALO ...c. (NYSE: VAR ) has received FDA 510(k) clearance...LC), an ultra-fine beam shaping,device for radiosu...bles clinicians to deliver,extremely precise radio...
...DON, Sept. 18 Morria Biopharmaceuticals Plc, a,pr...in-class novel,non-steroidal anti-inflammatory dru... Mazanet M.D., Ph.D. as its interim Chief Executiv...in both executive and,operational management in th...on the Board of numerous private and public,pharma...
... YORK, Sept. 18 Intra-Cellular Therapies today,an...monal compounds that,show promise in the treatment...olecule agents are specific and potent inhibitors ... regions of the brain. The Company,believes these ...oactive,sexual desire disorder (HSDD), a condition...
Other Biology Technology:Varian Medical Systems Receives FDA 510(k) Clearance for High-Definition Collimator That Enables Ultra-Fine Intensity-Modulated Radiosurgery 2Varian Medical Systems Receives FDA 510(k) Clearance for High-Definition Collimator That Enables Ultra-Fine Intensity-Modulated Radiosurgery 3Morria Biopharmaceuticals Plc Announces Appointment of Dr. Rosemary Mazanet as Interim Chief Executive Officer 2Intra-Cellular Therapies Provides Overview of its Proprietary Portfolio of Compounds for the Treatment of Female Sexual Dysfunction (FSD) 2Intra-Cellular Therapies Provides Overview of its Proprietary Portfolio of Compounds for the Treatment of Female Sexual Dysfunction (FSD) 3
(Date:12/4/2009)... This release is available in German . , A n...f Ageing could help to understand the positive eff...ious evidence from different organisms (fruit flie...creases longevity, but with a potential negative s...fruit fly reproduces less frequently with a reduce...
(Date:12/3/2009)..., Our ability to learn new information and adapt ... retain lifelong memories, appears to lie in the m...ording to a new study by NYU Langone Medicine Cent... week in the journal Nature . , The scientists... physiology and neuroscience at NYU School of Medi...
(Date:12/3/2009)..., ALBUQUERQUE, N.M. Most scientists believe that...ls that signal each other to emit toxins. The sign...y bacteria must be present to start the process. ,...ned that the very first stage of staph infection, ... form, occurs in a single cell and that this indiv...
Breaking Biology News(10 mins):How nutrition affects healthy aging 2Lifelong memories linked to stable nerve connections 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3Sonic Innovations Awarded Contract From U S Veterans Administration 54829 1Sonic Innovations Awarded Contract From U S Veterans Administration 54829 2Sonic Innovations Awarded Contract From U S Veterans Administration 54829 3Analysis of Biofuels Indirect Land Use Effects Finds the Science Lacking 3A Too Diffuse and Subject To Too Many Arbitrary Assumptions To Be Useful for 13624 1Analysis of Biofuels Indirect Land Use Effects Finds the Science Lacking 3A Too Diffuse and Subject To Too Many Arbitrary Assumptions To Be Useful for 13624 2Analysis of Biofuels Indirect Land Use Effects Finds the Science Lacking 3A Too Diffuse and Subject To Too Many Arbitrary Assumptions To Be Useful for 13624 3Health Experts Praise Intellicig Electronic Cigarette 54824 1Health Experts Praise Intellicig Electronic Cigarette 54824 2Health Experts Praise Intellicig Electronic Cigarette 54824 3
...y recently made a major breakthrough when they inv... hypothesis that some very, very small metal parti...cal processes such as converting chemical energy t... pollution. , The breakthrough, reported in this... also came with a surprise. By devising a way to w...
..., 2008) Conservation International (CI) today ann...eamWorks Animation SKG, Inc. (NYSE: DWA) in suppor...gered giant panda. , Yesterday in Los Angeles at ...reamWorks Animation,s summer blockbuster, Kung Fu ... Jeffrey Katzenberg pledged $1 million to CI,s eff...
...er will publish the International Journal of Soci... engineering publishing program. The quartely jou...ate of the social robotics field, how the field an...ture and their impact on society at large. , The ...ver a broad array of topics related to the study o...
Other Biology News:Conservation International gets support from Dreamworks Animation to protect giant pandas 2International Journal of Social Robotics debuts at Springer 2
... Vitamin D kit is an enzymeimmunoassay intended fo...min D (25-OH D) and other hydroxylated metabolites...ay technology eliminates the inconvenience of solv... facilitates automation on many ELISA processors. ...
...igh gel-strength agarose suitable for a wide range...l constant field to Pulsed Field Gel Electrophores...ion limits, Multi ABgarose can effectively separat...This in turn means reduced band diffusion, a probl...
Mouse Anti-Yersinia pestis F1 antigen Monoclonal Antibody, Unconjugated, Clone 1.F.1 from Abcam
Rabbit Anti-L Kynurenine Polyclonal Antibody, Unconjugated from Abcam
Biology Products: